阿司匹林可降低肺炎患者的心血管事件风险:大型初级保健数据库的既往事件率比分析
本研究从英国临床实践研究数据链(CPRD)提取50岁以上肺炎患者,采用倾向性评分匹配与既往事件率比(PERR)分析,纳入9864对阿司匹林使用者和非使用者。结果显示,阿司匹林使用与主要复合终点(缺血性卒中与心肌梗死)风险降低相关(调整后HR 0.64,95%CI 0.52-0.79),心肌梗死(HR 0.46)与卒中(HR 0.70)风险亦分别降低。
要点
- 肺炎后阿司匹林使用与缺血性卒中及心肌梗死复合终点风险降低相关。
- 心肌梗死(HR 0.46)和卒中(HR 0.70)的单项风险也均见降低。
- 该研究为观察性设计,尚不能据此确立阿司匹林在肺炎后的常规预防地位。
核心结论
- 在初级保健人群中,阿司匹林使用与肺炎后缺血事件风险降低相关,可能具有预防该并发症的潜在临床价值。
研究设计与样本
- 基于英国CPRD初级保健数据库的回顾性队列研究,纳入2019年1月前50岁以上肺炎患者,采用倾向性评分匹配与既往事件率比(PERR)分析控制混杂。
主要发现
- PERR分析显示阿司匹林使用者主要复合终点风险降低(调整后HR 0.64,95%CI 0.52-0.79)。
- 心肌梗死风险降低(HR 0.46,95%CI 0.30-0.72),卒中风险降低(HR 0.70,95%CI 0.55-0.91)。
临床怎么用
- 结果为观察性证据,提示对肺炎后缺血事件高风险患者可评估阿司匹林获益与出血风险的平衡,但不应据此常规处方。
局限性
- 为观察性数据库分析,尽管采用PERR与倾向性评分匹配控制混杂,仍不能完全排除残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischaemic stroke and myocardial infarction (MI) are common after pneumonia and are associated with long-term mortality. Aspirin may attenuate this risk and should be explored as a therapeutic option. METHODS: We extracted all patients with pneumonia (aged over 50 years) from the Clinical Practice Research Datalink (CPRD), a large UK primary care database, from inception until January 2019. We then performed a prior event rate ratio (PERR) analysis with propensity score matching (PSM), an approach that allows for control of measured and unmeasured confounding, with aspirin usage as the exposure and ischaemic events as the outcome. The primary outcome was the combined outcome of ischaemic stroke and MI. Secondary outcomes were ischaemic stroke and MI individually. Relevant confounders (smoking, comorbidities, age and gender) were included in the analysis. FINDINGS: 48 743 patients were eligible for matching. Of these, 9864 were aspirin users who were matched to 9864 non-users. Aspirin users had a reduced risk of the primary outcome (adjusted hazard ratio 0.64, 95% CI 0.52-0.79) in the PERR analysis. For both secondary outcomes, aspirin use was also associated with a reduced risk for MI (hazard ratio 0.46, 95% CI 0.30-0.72) and stroke (hazard ratio 0.70, 95% CI 0.55-0.91), respectively. INTERPRETATION: This study provides supporting evidence that aspirin use is associated with reduced ischaemic events after pneumonia in a primary care setting. This drug may have a future clinical role in preventing this important complication.
引用
- Hamilton F, Arnold D, Henley W, et al. Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database. Eur Respir J. 2021. PMID: 32943408. doi:10.1183/13993003.02795-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。